SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-19-021273
Filing Date
2019-11-01
Accepted
2019-11-01 14:46:18
Documents
2
Period of Report
2019-10-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1356
2 maherpoa.htm EX-24 6318
  Complete submission text file 0001437749-19-021273.txt   9361
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ARMISTICE CAPITAL 510 MADISON AVE., 7TH FLOOR NEW YORK NY 10022
Business Address
Maher Illya Keith (Reporting) CIK: 0001792777 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35285 | Film No.: 191186542